Ruthvik Malladi is currently the Director of Medical Affairs at Hemab Therapeutics and has previous experience as a Medical Science Liaison at Blueprint Medicines and a Postdoctoral Fellow in Medical Affairs at Alnylam Pharmaceuticals. Ruthvik served as an Adjunct Clinical Professor at Northeastern University from 2017 to 2019. They are also pursuing a Doctor of Pharmacy (Pharm.D.) degree at Northeastern University. Ruthvik's educational background includes completion of high school at West Windsor-Plainsboro High School South.
This person is not in the org chart
This person is not in any teams
This person is not in any offices